Stem to Launch 12 New Products in January Featuring, Cannabis-Infused Topicals, and a new CBD Product Line-Up from Patent Edibles -Pending Hemp Genetics
Acquisition of Driven Deliveries to Support Distribution Drive
BOCA RATON, FL, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Stem Holdings, Inc. (OTCQX: STMH CSE:STEM), a leading vertically-integrated cannabis and hemp branded products company with state-of-the-art cultivation, processing, extraction, retail, and distribution operations throughout the United States, announced that they will be starting 2021 with an exciting line-up of disruptive products beginning in Oregon and launching in all markets in which Stem operates. Stem has added a cutting-edge extraction laboratory to its commercial kitchen capabilities for full integration in production of these value-added, margin-accretive products. The pending acquisition of Driven Deliveries, Inc. later this month (OTCQB: DRVD) will support new distribution in current and new markets.
Cannavore™ Cannabis Confections – Just in time for the holidays, Stem’s Cannavore is launching two flavors for its award-winning caramels – Irish Cream and Hazelnut – two on trend flavors complementing our original Salted Caramel. Made with full spectrum solventless bubble hash, they are rich in cannabinoids and terpenes for consistent dosing and effectiveness.
Dose-ology™ Topicals – To condition skin all year round, Stem’s Dose-ology brand is launching its first cannabis-infused topicals featuring lotion, massage oil, and facial serum. Made with THC concentrate from Stem’s own TJ Gardens award-winning brand of cannabis, Dose-ology will feature the exact dose recommended by Stem Medical Holdings’ team led by Dr. Drore Eisen, to assure consumers that they will experience optimal products benefits with each and every usage.
Dose-ology™ CBD Topicals – Dose-ology will also enter the mass market with a line-up of four new broad-spectrum CBD-infused topical products that reflect Stem’s commitment to efficacious dosing and performance. They will initially be sold at select retailers and in e-commerce. The hemp grown for these products features patent-pending genetics that resist powdery mildew, and continues to be part of Stem’s work with Cornell University’s School of Agriculture.
“This is just the beginning of a new queue of disruptive products unlike any other company’s,” stated Adam Berk, CEO of Stem. “Our vertical integration from seed to extraction to production of finished goods distinguishes us from other brands in the marketplace, particularly as we leverage the expertise of our experience grow and extraction teams, and our increasing ability to fill distribution white space along with the upcoming direct-to-consumer capability offered by Driven.” He continued, “We will be closing on our acquisition of Driven this month and this will be a critical component of our go-to-market strategy, as will strategic collaborations to enthuse the market,” Berk concluded.
About Stem Holdings, Inc.
Stem Holdings, Inc. (OTCQX: STMH CSE: STEM) is a leading cannabis and hemp branded products company in the U.S. with proprietary capabilities in sustainable cultivation, processing, extraction, and R&D, as well as retail and distribution operations aligned with state-by-state regulations. Stem’s award-winning brands are the foundation of the Company’s expansion into current and new segments and markets, with exceptional and disruptive brands and products that benefit well-being. Stem’s expertise and scale will drive growth domestically and internationally, building value for shareholders.
Cautionary Note Regarding Forward-Looking Information
This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the management of Stem with respect to future business activities. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and include information regarding: (i) the ability of the Company to successfully achieve its business objectives, (ii) plans for expansion of Stem, (iii) expectations for other economic, business, and/or competitive factors, and (iv) anticipated growth.
Investors are cautioned that forward-looking information is not based on historical facts but instead reflect the management of Stem’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Stem believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws, including those related to taxation; the inability to locate and acquire suitable companies, properties and assets necessary to execute on the Company’s business plans; and increasing costs of compliance with extensive government regulation. This forward-looking information may be affected by risks and uncertainties in the business of Stem and market conditions.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Stem has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Stem does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
No securities regulatory authority has in any way passed upon the merits of the proposed transactions described in this news release or has approved or disapproved of the contents of this news release.
For further information, please contact:
Media Contact:
Mauria Betts
STEM HOLDINGS, INC.
Mauria@stemholdings.com
971.319.0303
Attachment